subscribeSubscribe
price-trendAsk Us
Fresenius Kabi Launches Gadoterate Meglumine Injection, USP

Fresenius Kabi Launches Gadoterate Meglumine Injection, USP
BUSINESSWIRE
04 Oct 2022
Share Share
Jiangsu Hengrui Medicine`s Generic Gadoterate Meglumine Receives Approval inU.S.

Jiangsu Hengrui Medicine`s Generic Gadoterate Meglumine Receives Approval inU.S.
FDA
15 Apr 2022
Share Share
Jiangsu Hengrui`s Generic Gadoterate Meglumine Receives Approval in the U.S.

Jiangsu Hengrui`s Generic Gadoterate Meglumine Receives Approval in the U.S.
FDA
11 Apr 2022
Share Share
Health Canada Recalls Dotarem Injection

Health Canada Recalls Dotarem Injection
Health Canada
22 Nov 2021
Share Share
GE Healthcare`s Generic Gadoterate Meglumine Receives Approval in US

GE Healthcare`s Generic Gadoterate Meglumine Receives Approval in US
FDA
06 Nov 2019
Share Share
GE Healthcare Announces USFDA Approval Macrocyclic MRI Contrast Agent Clariscan

GE Healthcare Announces USFDA Approval Macrocyclic MRI Contrast Agent Clariscan
BIOSPACE
04 Nov 2019
Share Share
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA

Gadolinium-based contrast agents: update from Guerbet LLC on U.S. FDA
PR NEWSWIRE
27 Dec 2017
Share Share
FDA Approves Guerbet`s Dotarem gadoterate meglumine Pediatric Patient Younger 2y

FDA Approves Guerbet`s Dotarem gadoterate meglumine Pediatric Patient Younger 2y
PR NEWSWIRE
05 Sep 2017
Share Share